Effectiveness of topical caffeine in cataract prevention: studies with galactose cataract.
白内障予防における局所カフェインの有効性:ガラクトース白内障を用いた研究 (機械翻訳の邦題)
記録の確認項目
- 研究デザイン
- その他の原著論文
- 対象
- 動物
- 出版年
- 2010
- 抄録の表示
- 表示あり
- 出版状態
- 有効な記録
- 状態確認日
- 2026/08/17
- 収集日
- 2026/08/03
- 鮮度
- 確認期限内
- 確認段階
- 自動処理
- 記録状態
- 公開
日本語要約(機械生成)
本研究は、ガラクトース血症ラットモデルを用いて、カフェインの局所投与が白内障形成を阻害する可能性を検討した。白内障は、若齢ラットに24%ガラクトース含有食を25日間与えて誘発した。対照群には湿潤剤としてヒドロキシプロピルメチルセルロースを含むプラセボ点眼薬を、実験群には同製剤に72mMカフェインを混合したものを投与した。その結果、カフェイン点眼は白内障の発生と進行を有意に抑制し、25日目には対照群の全例で水晶体全体に白濁が広がったのに対し、カフェイン群では透明性が維持された。また、カフェイン群では水晶体のグルタチオン濃度が対照群より高く維持され、形態変化も抑制された。これらの効果は、カフェインが活性酸素種を消去し、酸化ストレスを防ぐことに起因すると結論づけられた。局所カフェインは糖尿病性白内障への有用性が示唆される。
この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。
抄録
Purpose: The primary objective of the study was to investigate the possible inhibition of cataract formation by topical administration of caffeine using the galactosemic rat model. It was hypothesized that caffeine will do so by acting as scavenger of reactive oxygen species known to be generated under hyperglycemic conditions.Methods: Cataract was induced by feeding young rats a diet containing 24% galactose for a period of 25 days. A control group of such rats was treated with a placebo eye drop preparation containing hydroxy propyl methyl cellulose as a wetting agent. In the experimental group, the rats were treated with the above preparation mixed with 72 mM caffeine.Results: Administration of caffeine eye drops was found to significantly inhibit the onset as well as the progress of cataract formation. By day 25 on the galactose diet, all the animals in the control group developed advanced white opacity spread over the entire area of the lens. In the caffeine group, the formation of such opacity remained strikingly inhibited. The lenses remained largely transparent. The transparency data paralleled the higher concentration of glutathione maintained by caffeine treatment. Its levels in the placebo group were 0.8, 0.5, and 0.4 µmoles/g lens wt. on days 5, 15, and 25 against a consistent basal control value of ~3 µmoles/g over the entire period. In the caffeine group, the corresponding values were nearly 3 µmoles/g till day 15, but decreasing to ~2 µmoles/g on day 25. The levels were hence significantly higher than in the caffeine untreated group, remaining relatively closer to the basal controls. In addition, the compound was found effective in inhibiting morphological changes induced by galactose.Conclusions: Micromolar amounts of topical caffeine have been found to be significantly effective in inhibiting the formation of galactose cataract, strongly suggesting its possible usefulness against diabetic cataracts. The effects are attributed to its ability to prevent oxidative stress and consequent maintenance of tissue metabolic and transport functions, in addition to preventing the induction of apoptosis.
MeSH
PMID 21179241
原文・出典を見る →